Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ADC Therapeutics SA | 734,376 | reported | 13 Feb 2026 | tx 5+511,600−127,224 |
| MPM ACQUISITION CORP | 46,708 | reported | 26 Feb 2020 | tx 8+333,000−1,292 |
| Rubius Therapeutics, Inc. | 34,500 | reported | 31 Jan 2022 | tx 3+578,250 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Feb 2026 | GRANT_AWARD | ADC Therapeutics SA | 271,600 | 3.99 USD | |
| 13 Feb 2026 | TAX_WITHHOLDING | ADC Therapeutics SA | 25,880 | 3.99 USD | |
| 06 Dec 2025 | TAX_WITHHOLDING | ADC Therapeutics SA | 53,236 | 3.29 USD | |
| 13 Feb 2025 | GRANT_AWARD | ADC Therapeutics SA | 240,000 | 1.61 USD | |
| 06 Dec 2024 | TAX_WITHHOLDING | ADC Therapeutics SA | 48,108 | 3.13 USD | |
| 31 Jan 2022 | GRANT_AWARD | Rubius Therapeutics, Inc. | 34,500 | 0.00 USD | deriv |
| 31 Jan 2022 | GRANT_AWARD | Rubius Therapeutics, Inc. | 143,750 | 0.00 USD | deriv |
| 30 Nov 2020 | GRANT_AWARD | Rubius Therapeutics, Inc. | 400,000 | 0.00 USD | deriv |
| 26 Feb 2020 | SALE | MPM ACQUISITION CORP | 1,292 | 17.93 USD | |
| 20 Feb 2020 | GRANT_AWARD | MPM ACQUISITION CORP | 30,000 | — | |
| 20 Feb 2020 | GRANT_AWARD | MPM ACQUISITION CORP | 45,000 | 0.00 USD | deriv |
| 22 Feb 2019 | GRANT_AWARD | MPM ACQUISITION CORP | 15,000 | — | |
| 22 Feb 2019 | GRANT_AWARD | MPM ACQUISITION CORP | 55,000 | 0.00 USD | deriv |
| 13 Feb 2018 | GRANT_AWARD | MPM ACQUISITION CORP | 60,000 | 0.00 USD | deriv |
| 14 Sept 2017 | PURCHASE | MPM ACQUISITION CORP | 3,000 | 32.83 USD | |
| 15 May 2017 | GRANT_AWARD | MPM ACQUISITION CORP | 125,000 | 0.00 USD | deriv |